Arkolith/Insider Trading/RAIN/Form 4

Davis Aaron I.

DirectorRain Oncology Inc. (RAIN) · full profile →Form 4 · filed Jan 26, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 26, 2024Tender(U)80K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 26, 2024Disposed to issuer(D)20K——0
Jan 26, 2024Disposed to issuer(D)35K——0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001999371-24-000965) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML